Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Health Catalyst's Enterprise Value is $189.2 Mil.
Health Catalyst's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-242.7 Mil. Therefore, Health Catalyst's EV-to-EBIT ratio for today is -0.78.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Health Catalyst's Enterprise Value is $189.2 Mil.
Health Catalyst's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-192.4 Mil. Therefore, Health Catalyst's EV-to-EBITDA ratio for today is -0.98.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Health Catalyst's Enterprise Value is $189.2 Mil.
Health Catalyst's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $302.5 Mil. Therefore, Health Catalyst's EV-to-Revenue ratio for today is 0.63.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Health Catalyst's Enterprise Value is $189.2 Mil.
Health Catalyst's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.8 Mil. Therefore, Health Catalyst's EV-to-FCF ratio for today is -68.68.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Health Catalyst (NAS:HCAT) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Health Catalyst's current Enterprise Value is $189.2 Mil.
Health Catalyst's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-242.7 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Health Catalyst's current Enterprise Value is $189.2 Mil.
Health Catalyst's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-192.4 Mil.
Health Catalyst's current Enterprise Value is $189.2 Mil.
Health Catalyst's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $302.5 Mil.
Health Catalyst's current Enterprise Value is $189.2 Mil.
Health Catalyst's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $19.0 Mil.
Health Catalyst's current Enterprise Value is $189.2 Mil.
Health Catalyst's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst Enterprise Value Related Terms
Health Catalyst Enterprise Value Historical Data
* Premium members only.
The historical data trend for Health Catalyst's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HCAT vs CCLD, DH, OPRX: Enterprise Value Comparison
For the Health Information Services subindustry, Health Catalyst's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Health Catalyst's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Health Catalyst's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst (HCAT) has a Enterprise Value of $189.2 Mil as of Jun. 24, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Health Catalyst and its competitors.
Is Health Catalyst's Enterprise Value too high?
Health Catalyst's current Enterprise Value is $189.2 Mil. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's Enterprise Value compare to CCLD and DH?
Health Catalyst's Enterprise Value of $189.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Health Catalyst and its competitors. Health Catalyst's current Enterprise Value is $189.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.07, compared to a current price of $1.72 — trading 66.1% below its estimated fair value. The current Enterprise Value is $189.2 Mil. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Health Catalyst (HCAT), the current Enterprise Value is $189.2 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $1.72 is trading 66.1% below its estimated GF Value™ of $5.07.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
Enterprise Value: $189.2 Mil
GF Value™: $5.07 vs. price of $1.72 (66.1% below fair value)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score
Get the complete analysis for HCAT
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
